CTRI/2017/08/009529Completed未知
Evaluation of efficacy and safety profile of intense pulse light treatment in melasma
IPGMER and SSKM HOSPITA0 sites32 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 32
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.cases of melasma attending OPD consenting to participate in study through written informed consent.
- •2.patient above 18 years of age
Exclusion Criteria
- •1.patient unable or unwilling to give consent.
- •2.patient with unrealistic expectation.
- •3.patient with active infection,SLE,pregnancy or
- •on photosensitive mediacation.
- •4.patient on other form of treatment for melasma.
Investigators
Similar Trials
Withdrawn
Phase 3
Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack (RESUS-AMI)acute myocardial infarction with LVEF< 30%heart attack with heartfailure10011082NL-OMON40846niversity college Cork, Centre for Research in Vascular Biology Bio Sciences Institute15
Recruiting
Phase 2
Comparison of intracoronary selected CD 133+ bone marrow stem cells in cardiac recovery after acute myocardial infarct and left ventricular dysfunction: COMPARE-AMI a randomized controlled double blind clinical studyHeart failureACTRN12609001045202Miltenyi Biotech Inc.40
Completed
Phase 3
Intralesional methotrexate injection in alopecia areataIRCT20141209020250N6Vice chancellor of Research and Technology,Tehran University of Medical Sciences and Health Services40
Not yet recruiting
Phase 2
Therapeutic efficiency and safety assessment of intradermal platelet rich plasma combined with oral tranexamic acid in patients with facial melasmaFacial melasmaMelasmaTCTR20230317003WU grant, Walailak university20
Recruiting
Phase 4
â??Comparison of efficacy and safety ofintravenous injection of the drug ferric carboxymaltose vs iron sucrose in the treatment of iron deficiency anaemia during pregnancy â?? A randomized controlled trialâ??CTRI/2014/01/004369KLE Hospital230